14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 BPMC stock ended at $108.55. This is 2.16% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 5.90% from a day low at $103.31 to a day high of $109.41.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Feb 27, 2023 $38.38 $40.73 $38.33 $40.52 1 311 501
Feb 24, 2023 $40.94 $40.94 $37.82 $37.97 1 240 613
Feb 23, 2023 $42.55 $42.64 $41.03 $41.57 574 564
Feb 22, 2023 $43.41 $44.44 $42.56 $42.84 471 148
Feb 21, 2023 $45.63 $45.81 $43.27 $43.51 875 529
Feb 17, 2023 $44.71 $46.58 $43.93 $46.22 695 474
Feb 16, 2023 $44.92 $45.98 $43.59 $44.71 654 802
Feb 15, 2023 $44.35 $44.35 $43.42 $44.03 457 177
Feb 14, 2023 $44.14 $45.26 $43.33 $44.46 508 484
Feb 13, 2023 $43.19 $43.99 $42.09 $43.97 452 730
Feb 10, 2023 $41.92 $43.24 $41.16 $43.06 1 058 407
Feb 09, 2023 $44.41 $45.30 $43.98 $44.29 329 537
Feb 08, 2023 $45.79 $46.12 $43.93 $44.07 330 011
Feb 07, 2023 $45.42 $46.04 $44.40 $45.85 411 726
Feb 06, 2023 $45.53 $46.61 $45.12 $45.67 363 108
Feb 03, 2023 $48.05 $49.31 $44.83 $45.65 807 119
Feb 02, 2023 $46.87 $49.09 $46.31 $49.06 519 168
Feb 01, 2023 $46.35 $46.68 $45.02 $46.05 562 257
Jan 31, 2023 $46.71 $47.68 $46.28 $46.74 385 905
Jan 30, 2023 $47.54 $48.26 $46.29 $46.71 327 752
Jan 27, 2023 $47.23 $48.00 $47.01 $47.78 282 590
Jan 26, 2023 $47.04 $47.83 $46.09 $47.75 369 763
Jan 25, 2023 $47.68 $47.94 $46.02 $46.65 305 120
Jan 24, 2023 $46.51 $47.99 $45.73 $47.97 413 570
Jan 23, 2023 $46.58 $47.18 $45.11 $46.51 583 834
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT